Development of an Anti-Zika and Anti-Dengue IgM ELISA Assay: Evaluation of Cross Reactivity and Validation
- PMID: 36355890
- PMCID: PMC9693240
- DOI: 10.3390/tropicalmed7110348
Development of an Anti-Zika and Anti-Dengue IgM ELISA Assay: Evaluation of Cross Reactivity and Validation
Abstract
Zika and dengue viruses (ZIKV and DENV) have been considered major global threats to humans in the past decade. The two infections display similar epidemiological and clinical manifestations. They are transmitted by the same primary vector, accounting for the co-circulation of the two viruses in regions where they are endemic. Highly specific and sensitive serological assays that are able to detect ZIKV and DENV antibodies (Abs) during the acute and convalescent phases of infections would help to improve clinical management and disease control. We report the development and characterisation of two monoclonal Abs, the ZIKV 8-8-11 and the DENV 8G2-12-21, which recognise the Zika non-structural protein 1 (NS1) and the dengue virus type 2 envelope protein, respectively. Both mAbs were used to set up enzyme-linked immunosorbent assays (ELISAs) specific for the detection of anti-Zika immunoglobulin M (IgM) and anti-dengue IgM and whose performance was similar to commercially available kits. These kits, intended to be used with the CHORUS Instruments, are rapid and require ≤ 50 µL of human serum. These tests could represent an affordable and reliable option for the rapid diagnosis of both ZIKV and DENV infections in developing countries, where these flaviviruses are endemic.
Keywords: IgM; Zika; capture Elisa; cross-reaction; dengue.
Conflict of interest statement
All the authors declare to be “DIESSE Diagnostica Senese S.p.A. Società Benefit” employees.
Similar articles
-
Diagnostic performance of anti-Zika virus IgM, IgAM and IgG ELISAs during co-circulation of Zika, dengue, and chikungunya viruses in Brazil and Venezuela.PLoS Negl Trop Dis. 2021 Apr 19;15(4):e0009336. doi: 10.1371/journal.pntd.0009336. eCollection 2021 Apr. PLoS Negl Trop Dis. 2021. PMID: 33872309 Free PMC article.
-
Serological tests reveal significant cross-reactive human antibody responses to Zika and Dengue viruses in the Mexican population.Acta Trop. 2020 Jan;201:105201. doi: 10.1016/j.actatropica.2019.105201. Epub 2019 Sep 25. Acta Trop. 2020. PMID: 31562846
-
Comprehensive Evaluation of Differential Serodiagnosis between Zika and Dengue Viral Infections.J Clin Microbiol. 2019 Feb 27;57(3):e01506-18. doi: 10.1128/JCM.01506-18. Print 2019 Mar. J Clin Microbiol. 2019. PMID: 30541932 Free PMC article.
-
Serological cross-reactivity among common flaviviruses.Front Cell Infect Microbiol. 2022 Sep 15;12:975398. doi: 10.3389/fcimb.2022.975398. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 36189346 Free PMC article. Review.
-
Structural and immunological basis of cross-reactivity between dengue and Zika infections: Implications in serosurveillance in endemic regions.Front Microbiol. 2023 Mar 17;14:1107496. doi: 10.3389/fmicb.2023.1107496. eCollection 2023. Front Microbiol. 2023. PMID: 37007463 Free PMC article. Review.
Cited by
-
Evolving Landscape of Emerging Virus Diagnosis: Challenges and Innovations.Mol Biotechnol. 2025 Mar 5. doi: 10.1007/s12033-025-01385-w. Online ahead of print. Mol Biotechnol. 2025. PMID: 40042766 Review.
-
Extracellular Expression and Diagnostic Potential of Dengue Virus Type 3 E Protein Domain III Through Codon Optimization in Komagataella phaffii.Mol Biotechnol. 2025 Jul 3. doi: 10.1007/s12033-025-01468-8. Online ahead of print. Mol Biotechnol. 2025. PMID: 40608275
References
-
- Driggers R.W., Ho C.Y., Korhonen E.M., Kuivanen S., Jaaskelainen A.J., Smura T., Rosenberg A., Hill D.A., DeBiasi R.L., Vezina G., et al. Zika Virus Infection with Prolonged Maternal Viremia and Fetal Brain Abnormalities. N. Engl. J. Med. 2016;374:2142–2151. doi: 10.1056/NEJMoa1601824. - DOI - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous